Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 22Vitamin D Deficiency 20Prostatic Neoplasms 17Polycystic Ovary Syndrome 9Neoplasms 9Colonic Neoplasms 8Rectal Neoplasms 6Colorectal Neoplasms 6Osteoporosis 5Myelodysplastic Syndromes 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Cardiovascular Diseases 4Warts 3Ovarian Neoplasms 3Leukemia, Myeloid, Acute 3Leukemia 3Brain Neoplasms 3Adenomatous Polyps 3Pathologic Processes 2Pain 2Obesity 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Musculoskeletal Diseases 2Melanoma 2Male Urogenital Diseases 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2

Interventions

pembrolizumab 162Carboplatin 144Paclitaxel 125Cyclophosphamide 93130-nm albumin-bound paclitaxel 66Capecitabine 63Gemcitabine 54Doxorubicin 49Albumin-Bound Paclitaxel 45Taxes 42atezolizumab 40Cisplatin 38Nivolumab 34sacituzumab govitecan 32olaparib 32Epirubicin 32Docetaxel 28eribulin 27Specimen Handling 26Bevacizumab 26durvalumab 25camrelizumab 23Drug Therapy 22Biopsy 22Magnetic Resonance Spectroscopy 21toripalimab 18Radiotherapy 17spartalizumab 16Everolimus 15fludarabine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Triple Negative Breast Neoplasms × Cholecalciferol × Clear all
NCT04677816 2026-04-14

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Wake Forest University Health Sciences

Phase 2 Recruiting
50 enrolled
Breast

Vitamin D Deficiency, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡